Jarrett Disbrow, Chief Business Officer at AYTU BIOPHARMA, INC (AYTU), bought 16,666 shares at $1.50 ($25K) on 2025-06-09, disclosed to the SEC on 2025-06-10.
Open-market purchase of $25k AYTU by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AYTU | BUY | 2016-05-16 | $100K | — | Filing → |
| AYTU | BUY | 2016-01-21 | $200K | — | Filing → |